Global Information
회사소개 | 문의 | 위시리스트

유럽의 암진단 시장 : 매출 예측, 시장 전략, 공급업체의 시장 점유율 - 새로운 종양마커, 기술, 시장 기회

Argentina Clinical Chemistry Reagents and Analyzers Market Analysis: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation Review

리서치사 Venture Planning Group
발행일 상품 코드 445420
페이지 정보 영문 517 Pages
가격
US $ 1,500 ₩ 1,810,000 DataPack
US $ 2,750 ₩ 3,319,000 PDF by E-mail (Local License)
US $ 3,750 ₩ 4,526,000 PDF by E-mail (Global License)


유럽의 암진단 시장 : 매출 예측, 시장 전략, 공급업체의 시장 점유율 - 새로운 종양마커, 기술, 시장 기회 Argentina Clinical Chemistry Reagents and Analyzers Market Analysis: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 100 Tests, Technology and Instrumentation Review
발행일 : 페이지 정보 : 영문 517 Pages

유럽 국가(총 31개국)의 암진단 검사(종양마커 검사 등) 시장을 분석했으며, 진단 방법 개요, 현재의 기술 수준, 현재의 주요 진단약 및 검사 방법, 국가별·진단 방법별 동향 전망(향후 5년간), 주요 공급업체의 프로파일·제품 포트폴리오·사업 전략, 향후 시장 기회 등의 정보를 정리하여 전해드립니다.

1. 목차 및 도표

2. 국가별 시장 동향

  • 오스트리아
  • 벨기에
  • 불가리아
  • 크로아티아
  • 키프로스
  • 체코
  • 덴마크
  • 에스토니아
  • 핀란드
  • 프랑스
  • 독일
  • 그리스
  • 헝가리
  • 아이슬란드
  • 아일랜드
  • 이탈리아
  • 라트비아
  • 리투아니아
  • 몰타
  • 네덜란드
  • 노르웨이
  • 폴란드
  • 포르투갈
  • 루마니아
  • 세르비아
  • 슬로바키아
  • 슬로베니아
  • 스페인
  • 스웨덴
  • 스위스
  • 영국

3. 종양마커 분류

4. 각종 암/종양마커용 진단약 개발 및 출시 상황

  • ACTH 검사
  • AFP 검사
  • β-2 마이크로글로불린 검사
  • CA 15-3/27.29 검사
  • CA 19-9 검사
  • CA-125 검사
  • 칼시토닌 검사
  • CEA 검사
  • 에스트로겐 수용체 검사
  • 프로게스테론 수용체 검사
  • 페리틴 검사
  • 가스트린 검사
  • HCG 검사
  • 인슐린 검사
  • NSE 검사
  • 잠혈 검사
  • PAP Smear/HPV 검사
  • PAP 검사
  • PSA 검사
  • 림프구 세분류 검사(Lymphocyte Subclassification Tests)

5. 암진단의 잠재적 이용 가능성

  • 생화학표지자(Biochemical Marker)
  • 발암 유전자(Oncogenes)
  • 성장인자(Growth Factors)
  • 콜로니자극인자(Colony Stimulating Factors)
  • 림포카인(Lymphokines)
  • 면역조직화학 염색(Immunohistochemical Stain)
LSH 17.03.06

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Tests Analyzed in the Report:

Routine Clinical Chemistry

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.

Therapeutic Drug Monitoring (TDM)

Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam,
Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.

Endocrine Function

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, PO Ab, TSH.

Tumor Markers and Special Chemistry

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.

Immunoproteins

C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,
Immunofixation, Prealbumin, Protein Electrophoresis.

Current and Emerging Products

- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.

- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

Technology Assessment

- Assessment of current and emerging technologies, and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Strategic Recommendations

- New product development opportunities with significant market appeal. Alternative market penetration strategies. Potential market entry barriers and risks.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Contains 517 pages and 65 tables

Table of Contents

List of Tables

  • Austria Cancer Diagnostic Volume Forecasts by Test
  • Austria Cancer Diagnostics Sales Forecasts by Test
  • Belgium Cancer Diagnostic Volume Forecasts by Test
  • Belgium Cancer Diagnostics Sales Forecasts by Test
  • Bulgaria Cancer Diagnostic Volume Forecasts by Test
  • Bulgaria Cancer Diagnostics Sales Forecasts by Test
  • Croatia Cancer Diagnostic Volume Forecasts by Test
  • Croatia Cancer Diagnostics Sales Forecasts by Test
  • Cyprus Cancer Diagnostic Volume Forecasts by Test
  • Cyprus Cancer Diagnostics Sales Forecasts by Test
  • Czech Republic Cancer Diagnostic Volume Forecasts by Test
  • Czech Republic Cancer Diagnostics Sales Forecasts by Test
  • Denmark Cancer Diagnostic Volume Forecasts by Test
  • Denmark Cancer Diagnostics Sales Forecasts by Test
  • Estonia Cancer Diagnostic Volume Forecasts by Test
  • Estonia Cancer Diagnostics Sales Forecasts by Test
  • Finland Cancer Diagnostic Volume Forecasts by Test
  • Finland Cancer Diagnostics Sales Forecasts by Test
  • France Executive Summary Table: Total Cancer Diagnostic Test Volume and Sales Forecast by Market Segment
  • France, Estimated Cancer Death Rates Per 100,000 Population
  • France, Laboratories Performing Tumor Marker Tests by Market Segment
  • France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • France, Total Tumor Marker Test Volume Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Test Volume Forecast
  • France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • France, Commercial/Private Laboratories Marker Test Volume Forecast
  • France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Sales Forecast by Test
  • France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
  • France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
  • France, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
  • France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Total Tumor Marker Sales by Major Suppliers
  • France, AFP Testing Market Diagnostics Sales by Major Supplier
  • France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • France, CEA Testing Market Diagnostics Sales by Major Supplier
  • France, NSE Testing Market Diagnostics Sales by Major Supplier
  • France, PAP Testing Market Diagnostics Sales by Major Supplier
  • France, PSA Testing Market Diagnostics Sales by Major Supplier
  • Germany Executive Summary Table: Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • Germany, Estimated Cancer Death Rates Per 100,000 Population
  • Germany, Laboratories Performing Tumor Marker Tests by Market Segment
  • Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Germany, Total Tumor Marker Test Volume Forecast by Market Segment
  • Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
  • Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • Germany, Total Tumor Marker Sales Forecast by Market Segment
  • Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Calcitonin Test Volume and Diagnostic Sales Forecast by Market Segment
  • Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Total Tumor Marker Sales by Major Supplier
  • Germany, AFP Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CEA Testing Market Diagnostics Sales by Major Supplier
  • Germany, PSA Testing Market Diagnostics Sales by Major Supplier
  • Greece Cancer Diagnostic Volume Forecasts by Test
  • Greece Cancer Diagnostics Sales Forecasts by Test
  • Hungary Cancer Diagnostic Volume Forecasts by Test
  • Hungary Cancer Diagnostics Sales Forecasts by Test
  • Iceland Cancer Diagnostic Volume Forecasts by Test
  • Iceland Cancer Diagnostics Sales Forecasts by Test
  • Ireland Cancer Diagnostic Volume Forecasts by Test
  • Ireland Cancer Diagnostics Sales Forecasts by Test
  • Italy Executive Summary Table: Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estimated Cancer Death Rates Per 100,000 Population
  • Italy, Laboratories Performing Tumor Marker Tests by Market Segment
  • Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Italy, Total Tumor Marker Test Volume Forecast by Market Segment
  • Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
  • Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Total Tumor Marker Test Market Forecast by Market Segment
  • Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
  • Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Colon Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, S-100 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Total Tumor Markers Sales by Major Suppliers
  • Italy, AFP Testing Market Diagnostics Sales by Major Supplier
  • Italy, CEA Testing Market Diagnostics Sales by Major Supplier
  • Italy, PSA Testing Market Diagnostics Sales by Major Supplier
  • Latvia Cancer Diagnostic Volume Forecasts by Test
  • Latvia Cancer Diagnostics Sales Forecasts by Test
  • Lithuania Cancer Diagnostic Volume Forecasts by Test
  • Lithuania Cancer Diagnostics Sales Forecasts by Test
  • Malta Cancer Diagnostic Volume Forecasts by Test
  • Malta Cancer Diagnostics Sales Forecasts by Test
  • Netherlands Cancer Diagnostic Volume Forecasts by Test
  • Netherlands Cancer Diagnostics Sales Forecasts by Test
  • Norway Cancer Diagnostic Volume Forecasts by Test
  • Norway Cancer Diagnostics Sales Forecasts by Test
  • Poland Cancer Diagnostics Sales Forecasts by Test
  • Poland Cancer Diagnostic Volume Forecasts by Test
  • Portugal Cancer Diagnostics Sales Forecasts by Test
  • Portugal Cancer Diagnostic Volume Forecasts by Test
  • Romania Cancer Diagnostic Volume Forecasts by Test
  • Romania Cancer Diagnostics Sales Forecasts by Test
  • Serbia Cancer Diagnostic Volume Forecasts by Test
  • Serbia Cancer Diagnostics Sales Forecasts by Test
  • Slovakia Cancer Diagnostic Volume Forecasts by Test
  • Slovakia Cancer Diagnostics Sales Forecasts by Test
  • Slovenia Cancer Diagnostic Volume Forecasts by Test
  • Slovenia Cancer Diagnostics Sales Forecasts by Test
  • Spain Executive Summary Table: Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • Spain, Estimated Cancer Death Rates Per 100,000 Population
  • Spain, Laboratories Performing Tumor Marker Tests by Market Segment
  • Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Spain, Total Tumor Marker Test Volume Forecast by Market Segment
  • Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
  • Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Spain, Total Tumor Marker Sales Forecast by Market Segment
  • Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Total Tumor Marker Sales by Major Suppliers
  • Spain, AFP Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CEA Testing Market Diagnostics Sales by Major Supplier
  • Spain, PSA Testing Market Diagnostics Sales by Major Supplier
  • Sweden Cancer Diagnostic Volume Forecasts by Test
  • Sweden Cancer Diagnostics Sales Forecasts by Test
  • Switzerland Cancer Diagnostic Volume Forecasts by Test
  • Switzerland Cancer Diagnostics Sales Forecasts by Test
  • U.K. Executive Summary Table: Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • U.K., Estimated Cancer Death Rates Per 100,000 Population
  • U.K., Laboratories Performing Tumor Marker Tests by Market Segment
  • U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
  • U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Test Volume Forecast
  • U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • U.K., Total Tumor Marker Sales Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
  • U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Colon-Specific Antigen Test Volume and Diagnostics Sales by Market Segment
  • U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Total Tumor Marker Sales and Market Shares Forecast
  • U.K., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.K., PSA Testing Market Diagnostics Sales by Major Supplier
  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing
  • Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications in Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Back to Top
전화 문의
F A Q